Literature DB >> 15770369

Resource utilization and outcomes: effect of transfer on patients with ruptured abdominal aortic aneurysms.

Todd R Vogel1, Gary B Nackman, Lucy S Brevetti, J G Crowley, Maureen M Bueno, Adrienne Banavage, Karen Odroniec, Rocco G Ciocca, Alan M Graham.   

Abstract

We evaluated the transfer of patients with the diagnosis of a ruptured AAA (rAAA) from community centers to a tertiary care center. Our purpose was to identify factors associated with mortality and outcomes following the open repair of rAAA and to evaluate the differences between transferred and nontransferred patients. All patients who underwent repair of rAAA at our institution between 1995 and 2002 were retrospectively reviewed. Univariate and multivariate analysis was performed to identify patient specific factors on presentation and intraoperatively. Fifty-two patients underwent repair of rAAA, 20 patients were transferred to our institution. The overall mortality rate was 67%. The mortality rates for nontransferred and transferred groups were 69% and 65%, respectively. The incidence of mortality within 24 hr of surgery was significantly higher in the patients who were not transferred, 10 vs. 41% (p < 0.05). Patient-specific factors assessed for impact on survival by logistic regression included decreased body temperature on arrival to our institution (p = 0.02) and free rupture (p = 0.05). Of intraoperative factors tested, low systolic blood pressure was significantly associated with mortality (p = 0.05). No difference in total length of stay was noted. Transfer patients' length of stay in the intensive care unit was significantly greater than that of nontransferred patients (18.8 +/- vs. 7.3 +/- days, p < 0.05). The difference in ICU cost was dollar 36,000 among groups. We found the acceptance of transfer patients from community centers with rAAA did not adversely affect patient survival. Transferred patients had an over twofold increases in ICU days used. The identification of hypothermia was the single independent factor associated with poor survival and may be a marker for transfer selection. Given reduced reimbursements and increased utilization, tertiary care centers will need to consider the economic ramifications of accepting transfer patients with rAAA.

Entities:  

Mesh:

Year:  2005        PMID: 15770369     DOI: 10.1007/s10016-004-0160-0

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  6 in total

1.  Resident and fellow experiences after the introduction of endovascular aneurysm repair for abdominal aortic aneurysm.

Authors:  Teviah Sachs; Marc Schermerhorn; Frank Pomposelli; Philip Cotterill; James O'Malley; Bruce Landon
Journal:  J Vasc Surg       Date:  2011-05-28       Impact factor: 4.268

2.  In-hospital outcomes of ruptured abdominal aortic aneurysms: A single center experience.

Authors:  Niki Tadayon; Mohammad Mozafar; Sina Zarrintan
Journal:  J Cardiovasc Thorac Res       Date:  2022-03-06

3.  The effect of patient transfer on outcomes after rupture of an abdominal aortic aneurysm.

Authors:  Heather Hames; Thomas L Forbes; Jeremy R Harris; D Kirk Lawlor; Guy DeRose; Kenneth A Harris
Journal:  Can J Surg       Date:  2007-02       Impact factor: 2.089

4.  Early outcomes of patients transferred with ruptured suprarenal aneurysm or dissection.

Authors:  N Rudarakanchana; M Hamady; S Harris; E Afify; Rgj Gibbs; C D Bicknell; M P Jenkins
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

5.  Outcomes of regional transfers of ruptured abdominal aortic aneurysm in a UK vascular network.

Authors:  V K Proctor; M J Lee; A H Nassef
Journal:  Ann R Coll Surg Engl       Date:  2016-08-11       Impact factor: 1.891

6.  Ambulance smartphone tool for field triage of ruptured aortic aneurysms (FILTR): study protocol for a prospective observational validation of diagnostic accuracy.

Authors:  Thomas L Lewis; Rachael T Fothergill; Alan Karthikesalingam
Journal:  BMJ Open       Date:  2016-10-24       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.